NCT00161967View on ClinicalTrials.gov

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

PHASE4CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

November 30, 2008

Conditions
Encephalitis, Tick-Borne
Interventions
BIOLOGICAL

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Subjects receive one vaccination with either FSME-IMMUN 0.25 ml or FSME-IMMUN 0.5 ml, depending on their age.

Trial Locations (3)

4600

Grieskirchner Strasse 17, Wels

77694

Hauptstrasse 240, Kehl

22-400

Niepubliczny ZOZ, Zamość

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY